Which has preferable earnings & valuation, ILMN or QGEN?

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 8.30 $850M $5.36 44.56 Qiagen $2.09B 4.41 $424.88M $1.95 22.94

Is ILMN or QGEN more profitable?

Qiagen has a net margin of 19.49% compared to Illumina's net margin of 18.36%. Illumina's return on equity of 29.84% beat Qiagen's return on equity. Company Net Margins Return on Equity Return on Assets Illumina 18.36% 29.84% 12.17% Qiagen 19.49% 14.47% 8.34%

Does the media refer more to ILMN or QGEN?

In the previous week, Illumina had 6 more articles in the media than Qiagen. MarketBeat recorded 15 mentions for Illumina and 9 mentions for Qiagen. Illumina's average media sentiment score of 0.89 beat Qiagen's score of 0.70 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 8 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Qiagen 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TMO or ILMN?

In the previous week, Thermo Fisher Scientific had 8 more articles in the media than Illumina. MarketBeat recorded 23 mentions for Thermo Fisher Scientific and 15 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.18 beat Illumina's score of 0.89 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 14 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 8 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, ILMN or IQV?

IQVIA has higher revenue and earnings than Illumina. IQVIA is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 8.30 $850M $5.36 44.56 IQVIA $16.31B 2.73 $1.36B $8.06 33.58

Is ILMN or IQV more profitable?

Illumina has a net margin of 18.36% compared to IQVIA's net margin of 8.10%. IQVIA's return on equity of 30.25% beat Illumina's return on equity. Company Net Margins Return on Equity Return on Assets Illumina 18.36% 29.84% 12.17% IQVIA 8.10% 30.25% 6.54%

Does the media favor ILMN or IQV?

In the previous week, Illumina had 5 more articles in the media than IQVIA. MarketBeat recorded 15 mentions for Illumina and 10 mentions for IQVIA. Illumina's average media sentiment score of 0.89 beat IQVIA's score of 0.59 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 8 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IQVIA 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to A or ILMN?

In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 15 mentions for Illumina and 9 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.12 beat Illumina's score of 0.89 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 8 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, WAT or ILMN?

Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 13.17 $642.63M $4.01 105.82 Illumina $4.34B 8.30 $850M $5.36 44.56

Is WAT or ILMN more profitable?

Illumina has a net margin of 18.36% compared to Waters' net margin of 3.58%. Illumina's return on equity of 29.84% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Illumina 18.36% 29.84% 12.17%

Does the media favor WAT or ILMN?

In the previous week, Illumina had 1 more articles in the media than Waters. MarketBeat recorded 15 mentions for Illumina and 14 mentions for Waters. Illumina's average media sentiment score of 0.89 beat Waters' score of 0.57 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 8 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Illumina (ILMN) Competitors

$238.82 -0.80 (-0.33%)

As of 04:00 PM Eastern

Compare

ILMN vs. QGEN, TMO, IQV, A, and WAT

Should you buy Illumina stock or one of its competitors? Illumina's main competitors and comparable companies include Qiagen (QGEN), Thermo Fisher Scientific (TMO), IQVIA (IQV), Agilent Technologies (A), and Waters (WAT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Illumina compare to Qiagen?

Illumina (NASDAQ:ILMN) and Qiagen (NYSE:QGEN) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Illumina has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market. Comparatively, Qiagen has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Illumina presently has a consensus price target of $199.13, indicating a potential downside of 16.62%. Qiagen has a consensus price target of $43.51, indicating a potential downside of 2.75%. Given Qiagen's higher probable upside, analysts clearly believe Qiagen is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44
Qiagen	0 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.43

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	8.30	$850M	$5.36	44.56
Qiagen	$2.09B	4.41	$424.88M	$1.95	22.94

In the previous week, Illumina had 6 more articles in the media than Qiagen. MarketBeat recorded 15 mentions for Illumina and 9 mentions for Qiagen. Illumina's average media sentiment score of 0.89 beat Qiagen's score of 0.70 indicating that Illumina is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	8 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Qiagen	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Qiagen has a net margin of 19.49% compared to Illumina's net margin of 18.36%. Illumina's return on equity of 29.84% beat Qiagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	18.36%	29.84%	12.17%
Qiagen	19.49%	14.47%	8.34%

89.4% of Illumina shares are held by institutional investors. Comparatively, 70.0% of Qiagen shares are held by institutional investors. 2.9% of Illumina shares are held by company insiders. Comparatively, 9.0% of Qiagen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Illumina beats Qiagen on 13 of the 17 factors compared between the two stocks.

How does Illumina compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.47	$6.70B	$18.59	35.47
Illumina	$4.34B	8.30	$850M	$5.36	44.56

Thermo Fisher Scientific has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Illumina has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

Thermo Fisher Scientific currently has a consensus target price of $624.64, suggesting a potential downside of 5.28%. Illumina has a consensus target price of $199.13, suggesting a potential downside of 16.62%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, research analysts plainly believe Thermo Fisher Scientific is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44

In the previous week, Thermo Fisher Scientific had 8 more articles in the media than Illumina. MarketBeat recorded 23 mentions for Thermo Fisher Scientific and 15 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.18 beat Illumina's score of 0.89 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	14 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	8 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Illumina has a net margin of 18.36% compared to Thermo Fisher Scientific's net margin of 15.04%. Illumina's return on equity of 29.84% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Illumina	18.36%	29.84%	12.17%

Summary

Thermo Fisher Scientific beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to IQVIA?

Illumina (NASDAQ:ILMN) and IQVIA (NYSE:IQV) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Illumina has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

IQVIA has higher revenue and earnings than Illumina. IQVIA is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	8.30	$850M	$5.36	44.56
IQVIA	$16.31B	2.73	$1.36B	$8.06	33.58

Illumina currently has a consensus price target of $199.13, indicating a potential downside of 16.62%. IQVIA has a consensus price target of $248.00, indicating a potential downside of 8.38%. Given IQVIA's stronger consensus rating and higher probable upside, analysts plainly believe IQVIA is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

In the previous week, Illumina had 5 more articles in the media than IQVIA. MarketBeat recorded 15 mentions for Illumina and 10 mentions for IQVIA. Illumina's average media sentiment score of 0.89 beat IQVIA's score of 0.59 indicating that Illumina is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	8 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.4% of Illumina shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 2.9% of Illumina shares are held by insiders. Comparatively, 1.7% of IQVIA shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Illumina has a net margin of 18.36% compared to IQVIA's net margin of 8.10%. IQVIA's return on equity of 30.25% beat Illumina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	18.36%	29.84%	12.17%
IQVIA	8.10%	30.25%	6.54%

Summary

IQVIA beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends.

Agilent Technologies has a net margin of 19.53% compared to Illumina's net margin of 18.36%. Illumina's return on equity of 29.84% beat Agilent Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.53%	24.45%	13.09%
Illumina	18.36%	29.84%	12.17%

Agilent Technologies has higher revenue and earnings than Illumina. Agilent Technologies is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	6.58	$1.30B	$5.08	31.90
Illumina	$4.34B	8.30	$850M	$5.36	44.56

Agilent Technologies has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, Illumina has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market.

89.4% of Illumina shares are owned by institutional investors. 2.9% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 15 mentions for Illumina and 9 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.12 beat Illumina's score of 0.89 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	8 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies currently has a consensus price target of $170.33, indicating a potential upside of 5.11%. Illumina has a consensus price target of $199.13, indicating a potential downside of 16.62%. Given Agilent Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Agilent Technologies is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44

Summary

Agilent Technologies beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Waters?

Waters (NYSE:WAT) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	13.17	$642.63M	$4.01	105.82
Illumina	$4.34B	8.30	$850M	$5.36	44.56

Waters currently has a consensus target price of $434.60, suggesting a potential upside of 2.42%. Illumina has a consensus target price of $199.13, suggesting a potential downside of 16.62%. Given Waters' stronger consensus rating and higher probable upside, equities analysts plainly believe Waters is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44

Illumina has a net margin of 18.36% compared to Waters' net margin of 3.58%. Illumina's return on equity of 29.84% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Illumina	18.36%	29.84%	12.17%

In the previous week, Illumina had 1 more articles in the media than Waters. MarketBeat recorded 15 mentions for Illumina and 14 mentions for Waters. Illumina's average media sentiment score of 0.89 beat Waters' score of 0.57 indicating that Illumina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	8 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waters has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Illumina has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

94.0% of Waters shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.3% of Waters shares are held by company insiders. Comparatively, 2.9% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Illumina beats Waters on 10 of the 17 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ILMN vs. The Competition

Export

Metric	Illumina	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$36.18B	$10.40B	$7.26B	$12.97B
Dividend Yield	N/A	1.46%	2.53%	12.80%
P/E Ratio	44.56	56.96	214.53	21.21
Price / Sales	8.30	107.71	647.62	90.51
Price / Cash	35.69	27.47	28.04	34.72
Price / Book	13.40	5.71	10.56	6.36
Net Income	$850M	$56.67B	$3.49B	$358.17M
7 Day Performance	14.70%	4.48%	-0.23%	0.54%
1 Month Performance	8.85%	0.32%	-2.80%	-2.95%
1 Year Performance	132.43%	28.96%	18.25%	6.08%

Illumina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ILMN Illumina	2.2203 of 5 stars	$238.82 -0.3%	$199.13 -16.6%	+133.2%	$36.18B	$4.34B	44.56	8,650
QGEN Qiagen	3.8276 of 5 stars	$42.37 -2.5%	$43.93 +3.7%	-10.4%	$8.96B	$2.09B	21.71	5,654	Gap Up
TMO Thermo Fisher Scientific	3.8305 of 5 stars	$603.43 -1.7%	$624.64 +3.5%	+35.6%	$226.94B	$44.56B	32.46	125,000	Positive News
IQV IQVIA	3.4965 of 5 stars	$259.49 -3.1%	$243.63 -6.1%	+42.4%	$44.07B	$16.98B	32.19	93,000
A Agilent Technologies	4.4004 of 5 stars	$146.80 -2.7%	$170.33 +16.0%	+23.8%	$42.53B	$7.37B	28.90	18,100	Positive News Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ILMN) was last updated on 9/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Illumina (ILMN) Competitors